MarketPulse — Real-Time Financial News & Market Analysis

Latest News

15,984 articles
Mon, Mar 16
The Motley FoolThe Motley Fool··Harsh Chauhan

Beyond Nvidia: Why Alphabet and Snowflake May Offer Better AI Upside

Nvidia faces valuation headwinds despite strong growth. Alphabet and Snowflake offer broader AI exposure with potentially better risk-reward profiles.
NVDAGOOGGOOGLSNOWcloud computingartificial intelligence
BenzingaBenzinga··Badar Shaikh

Newsom Blasts Trump Over $3.70 Gas As Iran Tensions Boost Oil Profits

California Governor Newsom criticizes surging gas prices hitting $3.70 nationally, $5.51 statewide, costing Americans $1.5B extra weekly amid Iran conflict.
TSLATrump administrationStrait of Hormuz
The Motley FoolThe Motley Fool··Manali Pradhan, Cfa

Microsoft Poised to Dominate AI Software Monetization Wave in 2026

Microsoft's Copilot ecosystem drives recurring AI revenue through 15M Microsoft 365 seats and 4.7M GitHub subscribers, positioning the company as prime 2026 beneficiary.
MSFTcloud infrastructureenterprise software
BenzingaBenzinga··Prnewswire

KLYG Cuts Losses 85% Despite Revenue Dip, Secures FDA Win for Fusion Implants

$KLYG reported 85% net loss improvement to $138.6K on $3.05M revenue, secured FDA clearance for Fusion™ cranial implants, rejected acquisition offer.
KLYGFDA clearancenet loss improvement
The Motley FoolThe Motley Fool··Daniel Sparks

Palantir's AI Boom Masks Valuation Concerns as Amazon Offers Better Risk-Reward

Palantir's 70% growth masks 240x P/E valuation and slowing contract growth. Amazon offers superior risk-reward with 24% AWS growth and 29x P/E.
AMZNPLTRvaluationcapital expenditure
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Ultragenyx Faces Securities Lawsuit Over Misleading Drug Efficacy Claims

Securities class action filed against $RARE for allegedly misrepresenting setrusumab efficacy data. Investors may claim damages; lead plaintiff deadline April 6, 2026.
RAREsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Unknown

New Pepeto Bridge Tackles Ethereum Gas Fees While XRP Eyes $100 Target

Pepeto launches Ethereum bridge eliminating gas fees, presales exceed $8M. XRP analyst targets $100; institutional forecasts suggest $5-$10 by 2026.
XRPCETHVXRP price predictioncryptocurrency presale
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Alight Stock Plunges 38% on Q4 Results, Triggering Securities Investigation

Alight (NYSE: $ALIT) stock crashed 38.2% after weak Q4 2025 earnings. Law firm investigates potential securities violations over alleged misleading disclosures.
ALITsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Inovio Faces Securities Class Action Over Device Defects, Missed Regulatory Timelines

Rosen Law Firm files securities class action against Inovio Pharmaceuticals ($INO) alleging misleading statements on manufacturing deficiencies and overstated regulatory prospects. Lead plaintiff deadline April 7, 2026.
INOsecurities class actionmisleading statements
The Motley FoolThe Motley Fool··Adria Cimino

Vertex Pharma's $600 Target Hinges on Diversification Beyond Cystic Fibrosis

Vertex Pharmaceuticals eyes 25% stock upside to $600 as it expands beyond cystic fibrosis with new drug approvals and kidney disease candidate povetacicept.
VRTXbiotechrevenue growth
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Camping World Under Fire in Securities Lawsuit Over Alleged Inventory, Demand Misstatements

Rosen Law Firm files class action lawsuit against Camping World Holdings over alleged misstatements regarding inventory management and consumer demand projections.
CWHINOTCOMsecurities fraudclass action lawsuit
The Motley FoolThe Motley Fool··Courtney Carlsen

Nuclear Fuel Race Heats Up: Why Centrus Outpaces Oklo Despite Joint Venture

Oklo and Centrus Energy partner on HALEU fuel production. Centrus rated superior due to profitable operations; Oklo years from commercialization despite Meta deal.
OKLOMETALEUnuclear energyjoint venture
Sun, Mar 15
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Pepeto's AI Security Upgrade Attracts Whales as XRP Targets $10 on Policy Tailwinds

Pepeto launches AI-powered security upgrade while XRP whales enter presale ahead of anticipated Binance listing, with bullish price targets around $10 driven by favorable policy and macro conditions.
XRPCXRP price predictionBinance listing
GlobeNewswire Inc.GlobeNewswire Inc.··Unknown

Ethereum-Based Pepeto Eyes Binance Listing as Cardano Charts Recovery Path

Ethereum-based Pepeto advances Binance listing with $8M presale complete. Cardano pursues ecosystem growth via Midnight sidechain and LayerZero integration with $1.80-$2.20 price targets.
ETHVcryptocurrencyprice prediction
The Motley FoolThe Motley Fool··Jonathan Ponciano

Water Giant Primo Brands Surges 27% as Major Fund Stakes $7.5M Position

Solas Capital acquires $7.53M stake in Primo Brands, signaling confidence in water giant's 29% sales growth and 27% year-to-date stock appreciation.
PRMBinstitutional investmentmargin expansion
The Motley FoolThe Motley Fool··Jonathan Ponciano

Euronet Stock Slides 30% as Activist Investor Bets $6M on Turnaround

Solas Capital acquired $5.59M stake in Euronet Worldwide as stock declined 30% YoY, despite company reporting $4.24B revenue and projecting 10-15% earnings growth.
EEFTstock declinefintech
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Signet Jewelers' 70% Rally Erases Value Case as Luxury Demand Cools

Signet Jewelers' 70% rally erases its value appeal amid weakening luxury demand and rising precious metal costs, leaving the stock fully to expensively valued.
SIGsame-store sales declineinflation impact
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Target Slashes 3,000 Prices as Inflation Squeeze Tests Upscale Positioning

Target cuts 3,000 item prices to compete amid inflation, but risks eroding premium positioning. Success depends on retaining customers while maintaining brand differentiation against Walmart.
WMTTGTconsumer spendinginflation
The Motley FoolThe Motley Fool··Jonathan Ponciano

EyePoint Pharmaceuticals Attracts $20M Strategic Investment Amid 93% Annual Surge

Parkman Healthcare Partners invests $20M in EyePoint Pharmaceuticals as shares surge 93% annually ahead of mid-2026 Phase 3 data for retinal disease treatment DURAVYU.
CVSDXCMEYPTPODDbiotechPhase 3 trials
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Two Major Securities Class Actions Target BlackRock TCP and Plug Power Over Disclosure Failures

Law firm pursues class actions against BlackRock TCP and Plug Power for alleged disclosure violations, citing NAV misstatements and misrepresented loan prospects.
PLUGTCPCsecurities fraudclass action lawsuit